Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 23, 2010 | December 30, 2010 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 23, 2010 · Filed December 30, 2010
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 168,071 |
Reported balance
After 2010-12-23 transaction · row 1
1 source rowRow 1 · 2010-12-23 · Gift · Disposed 1,054 · Balance 168,071 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 15,152 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,152 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 28, 2010. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife for daughter | 295 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 295 F2: The reporting person disclaims beneficial ownership of all securities held by his daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife for daughter | 296 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 296 F2: The reporting person disclaims beneficial ownership of all securities held by his daughters. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 28, 2010.
F2: The reporting person disclaims beneficial ownership of all securities held by his daughters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 04, 2009 Filed Feb 6, 2009 23:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,028 | $45.45 | $46,721.37 |
DisclosureSEC source: 0001104659-09-007393 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2009 Filed Feb 3, 2009 00:28 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 10,067 | $0.00 Strike: $53.40 | $0.00 |
DisclosureSEC source: 0001104659-09-005788 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 10,067 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 29, 2009 Filed Feb 3, 2009 00:28 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,067 | $55.27 | $280,053.09 |
DisclosureSEC source: 0001104659-09-005788 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,775 Read SEC document |
| January 29, 2009 Filed Feb 3, 2009 00:28 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,000 | $55.28 | $276,400.00 |
DisclosureSEC source: 0001104659-09-005788 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,842 Read SEC document |
| January 29, 2009 Filed Feb 3, 2009 00:28 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 10,067 | $53.40 | $537,577.80 |
DisclosureSEC source: 0001104659-09-005788 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 10,630 | $0.00 Strike: $57.72 | $0.00 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · derivative · entry 10 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,630 Underlying: Common shares · 10,630 shares Expires 2011-02-08 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,051 | $0.00 Strike: $57.72 | $0.00 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · derivative · entry 9 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,051 Underlying: Common shares · 2,051 shares Expires 2011-07-08 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 12,200 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,028 Underlying: Common shares · 12,200 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,378 | $0.00 Strike: $44.61 | $0.00 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,378 shares Expires 2011-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 12,681 | $57.72 | $731,947.32 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,775 Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 12,200 | $45.45 | $554,475.36 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2008 Filed Sep 2, 2008 23:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,378 | $44.61 | $106,088.29 |
DisclosureSEC source: 0001104659-08-056455 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2008 Filed Jul 24, 2008 21:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,000 | $57.55 | $287,750.00 |
DisclosureSEC source: 0001104659-08-047505 · a4.xml · nonDerivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,878 Read SEC document |
| July 22, 2008 Filed Jul 24, 2008 21:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,800 | $57.53 | $103,554.00 |
DisclosureSEC source: 0001104659-08-047505 · a4.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,878 Read SEC document |
| July 22, 2008 Filed Jul 24, 2008 21:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,100 | $57.52 | $63,272.00 |
DisclosureSEC source: 0001104659-08-047505 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,678 Read SEC document |
| July 22, 2008 Filed Jul 24, 2008 21:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,200 | $57.51 | $69,012.00 |
DisclosureSEC source: 0001104659-08-047505 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,778 Read SEC document |
| July 22, 2008 Filed Jul 24, 2008 21:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 20,900 | $57.50 | $1,201,750.00 |
DisclosureSEC source: 0001104659-08-047505 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,978 Read SEC document |
| May 30, 2008 Filed Jun 2, 2008 19:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 11,914 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001104659-08-037266 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,914 Underlying: Common shares · 11,914 shares Expires 2011-07-08 F3 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b(3). Read SEC document |
| May 30, 2008 Filed Jun 2, 2008 19:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 13,582 | $0.00 Strike: $44.61 | $0.00 |
DisclosureSEC source: 0001104659-08-037266 · a4.xml · derivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,378 Underlying: Common shares · 13,582 shares Expires 2011-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b(3). Read SEC document |
| May 30, 2008 Filed Jun 2, 2008 19:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 11,914 | $55.96 | $666,707.44 |
DisclosureSEC source: 0001104659-08-037266 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,878 Read SEC document |
| May 30, 2008 Filed Jun 2, 2008 19:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 13,582 | $44.61 | $605,925.62 |
DisclosureSEC source: 0001104659-08-037266 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 17,954 | $0.00 Strike: $42.94 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 17 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 17,954 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 17,395 | $0.00 Strike: $42.90 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 16 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 17,395 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 14,193 | $0.00 Strike: $54.39 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 15 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,193 Underlying: Common shares · 14,193 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 16,672 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 14 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 16,672 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 21,933 | $0.00 Strike: $54.39 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 13 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,933 Underlying: Common shares · 21,933 shares Expires 2014-03-30 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 26,601 | $0.00 Strike: $38.63 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 12 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 26,601 shares Expires 2014-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 31,465 | $0.00 Strike: $54.39 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 11 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,465 Underlying: Common shares · 31,465 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 822 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · derivative · entry 10 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 822 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 67,591 | $54.39 | $3,676,274.49 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,210 Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 17,954 | $42.94 | $770,944.76 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 17,395 | $42.90 | $746,245.50 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 16,672 | $41.03 | $684,080.50 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 26,601 | $38.63 | $1,027,484.91 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2008 Filed Mar 21, 2008 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 822 | $33.23 | $27,316.21 |
DisclosureSEC source: 0001104659-08-019086 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2008 Filed Mar 5, 2008 01:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,630 | $54.22 | $196,818.60 |
DisclosureSEC source: 0001104659-08-015212 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,357 Read SEC document |
| February 19, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 584 | $56.00 | $32,704.58 |
DisclosureSEC source: 0001104659-08-011829 · a4.xml · nonDerivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,987 Read SEC document |
| February 19, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $55.99 | $16,797.00 |
DisclosureSEC source: 0001104659-08-011829 · a4.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,571 Read SEC document |
| February 18, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,223 | $55.55 | $67,937.65 |
DisclosureSEC source: 0001104659-08-011829 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,871 Read SEC document |
| February 17, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,717 | $55.55 | $150,929.35 |
DisclosureSEC source: 0001104659-08-011829 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,094 Read SEC document |
| February 15, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 97,700 | $0.00 Strike: $55.56 | $0.00 |
DisclosureSEC source: 0001104659-08-011829 · a4.xml · derivative · entry 9 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,700 Underlying: common shares · 97,700 shares Expires 2018-02-14 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 32,567on 2/15/09, 32,567 on 2/15/10 and 32,566 on 2/15/11. Read SEC document |
| February 15, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 24,100 | $55.56 | $1,338,996.00 |
DisclosureSEC source: 0001104659-08-011829 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,811 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| December 27, 2007 Filed Dec 27, 2007 23:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,286 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0001104659-07-091115 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,286 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 27, 2007 Filed Dec 27, 2007 23:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 6,691 | $0.00 Strike: $52.25 | $0.00 |
DisclosureSEC source: 0001104659-07-091115 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 6,691 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 27, 2007 Filed Dec 27, 2007 23:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,977 | $57.58 | $516,850.78 |
DisclosureSEC source: 0001104659-07-091115 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,711 Read SEC document |
| December 27, 2007 Filed Dec 27, 2007 23:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,286 | $43.73 | $99,966.78 |
DisclosureSEC source: 0001104659-07-091115 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2007 Filed Dec 27, 2007 23:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 6,691 | $52.25 | $349,624.15 |
DisclosureSEC source: 0001104659-07-091115 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,719 | $0.00 Strike: $58.15 | $0.00 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · derivative · entry 10 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,719 Underlying: Common shares · 1,719 shares Expires 2011-02-08 F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,731 | $0.00 Strike: $58.15 | $0.00 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · derivative · entry 9 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,731 Underlying: Common shares · 1,731 shares Expires 2014-02-19 F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 07, 2007 Filed Dec 11, 2007 00:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,200 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-07-088058 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,228 Underlying: Common shares · 2,200 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.